Brussels, Belgium

Pierre Grognet


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 81(Granted Patents)


Company Filing History:


Years Active: 2002-2004

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Pierre Grognet: Innovator in Pharmaceutical Compositions

Introduction

Pierre Grognet is a notable inventor based in Brussels, Belgium. He has made significant contributions to the field of pharmaceutical compositions, particularly in periodontology. With a total of 2 patents, Grognet's work focuses on innovative methods for drug delivery.

Latest Patents

Grognet's latest patents include the "Use of gellable pharmaceutical compositions in periodontology." This patent describes a method for preparing a fluid pharmaceutical composition that allows for the controlled release of at least one active substance. The method involves mixing a therapeutically effective amount of at least one active substance, from 3 to 55% by weight of phospholipid, from 16 to 72% by weight of pharmaceutically acceptable solvent, and from 4 to 52% by weight of fatty acid. The composition has the property of gelling instantaneously in the presence of an aqueous phase. Another patent, "Use of pharmaceutical compositions capable of being gelled in periodontology," outlines a similar method for preparing a fluid pharmaceutical composition with controlled release capabilities.

Career Highlights

Pierre Grognet is currently associated with UCB S.A., a global biopharmaceutical company. His work at UCB has allowed him to focus on developing innovative solutions in the pharmaceutical industry. Grognet's expertise in creating gellable compositions has positioned him as a key player in periodontology.

Collaborations

Throughout his career, Grognet has collaborated with notable colleagues, including Domenico Fanara and Henri Vranckx. These collaborations have contributed to the advancement of research and development in pharmaceutical compositions.

Conclusion

Pierre Grognet's contributions to the field of pharmaceutical compositions demonstrate his commitment to innovation and improvement in drug delivery methods. His patents reflect a deep understanding of the complexities involved in periodontology, making him a valuable asset to the industry.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…